Endovascular Engineering (E2) has secured an oversubscribed $42m in a Series B funding round to further its clot removal technology platform, Hēlo PE thrombectomy system, targeting venous ...

In people with a life-threatening clot and no identification of what caused it, or if something caused it that can't be fixed ...

Feb. 18, 2025 /PRNewswire/ -- Endovascular Engineering, Inc. ("E2") has secured $42 million in an oversubscribed Series B financing to advance its next generation clot removal technology platform ...

A blood clot in the lung, or pulmonary embolism, affects arteries and can restrict blood flow to the lungs, making it a life-threatening condition. Once caught, the situation can typically be ...

My medical providers ran several blood tests, but no known reason was found to have caused the PE. My cardiologist recommended staying on Eliquis for one year because of the severity of the clot.